Samir Melki, MD, PHD, Founder
Meet Dr. Melki – Founder of Boston Vision
Samir Melki MD Ph.D. is currently a charter fellow at the World College of Refractive Surgery and completed a fellowship in Cornea and Refractive Surgery at the Massachusetts Eye and Ear Infirmary (Harvard Medical School) in 2000. Since 2015, he’s also been a part-time associate professor of Ophthalmology at Harvard Medical School.
His other teaching activities include a fellowship program at Boston Vision and a collaboration with Boston University to advise students undergoing a Master’s Degree in Health Sciences. He’s also been a tutor at Harvard Medical School since 2008.
As an ophthalmologist, he splits his time between his private practice at Boston Vision and at the Massachusetts Eye and Ear at the Beth Israel Deaconess Medical Center.
His previous education included an MD Ph.D. from Vanderbilt University and an Ophthalmology residency at Georgetown University. Dr. Melki founded Boston Vision in 2000 and has pursued an academically oriented practice since.
He is a member of a number of professional societies including The Cornea Society, American Academy of Ophthalmology, American Society of Cataract and Refractive Surgery, Association for Research in Vision & Ophthalmology, and the International Society of Refractive Surgery.
Dr. Melki was the Medical Director for Ophthalmology at the UK Specialist Hospitals from 2005 till 2013 where he established and managed quality controls for approximately 20,000 cataract procedures. In 2018, he was a visiting professor at Georgetown University, and in 2022, he was the Distinguished Guest Faculty at the Buffalo University Ophthalmology Department.
His academic activities have led to many accomplishments. These include the publication of many peer-reviewed articles as well as being included in several textbooks.
Dr. Melki designed several surgical instruments, was the first surgeon to implant a phakic IOL in Boston, and was the first person to implant a device during cataract surgery to wirelessly measure intraocular pressure in a patient with glaucoma. He has been key to introducing Keratoprosthesis surgery to Lebanon and South West England. Dr. Melki’s research endeavors have also included his participation in a clinical trial to measure the effect of corneal collagen crosslinking on keratoconus patients.
Dr. Melki’s hobbies include traveling, skiing, scuba diving, and biking. He enjoys photography and has published a collection of his work at www.freezingfires.com